New antiviral targets common viruses - including COVID-19 and Zika
New antiviral targets common viruses – including COVID-19 and Zika
Hebrew University’s ViroBlock announces preliminary success of anti-viral drug platform. ViroBlock, a startup company founded by Hebrew University of Jerusalem (HU) researchers, has developed a new drug platform for rapidly generating anti-viral drugs that target proteins common to all viruses. “Currently, there are no efficient, validated platforms for rapidly generating anti-viral drugs,” says…
View On WordPress













